首页> 外文会议>Conference on International Symposium on Medical Information Processing and Analysis >Differentiating Clear Cell Renal Cell Carcinoma from Oncocytoma using Curvelet Transform Analysis of Multiphase CT: Preliminary Study
【24h】

Differentiating Clear Cell Renal Cell Carcinoma from Oncocytoma using Curvelet Transform Analysis of Multiphase CT: Preliminary Study

机译:利用多相CT曲面变换分析来区分透明细胞肾细胞癌:初步研究

获取原文

摘要

Clinical imaging techniques have low accuracy in differentiating malignant tumors such as clear cell Renal Cell Carcinoma(ccRCC) and benign tumors such as oncocytoma. Texture metrics i.e., metrics assessing the variations in grey-levels ofintensity making up a region of interest extracted from routine clinical images have shown promising results in achievingthis objective. To explore the relationship between tumor behavior and texture metrics from images, we test theeffectiveness of 2D Curvelet Transform-based texture analysis in differentiating between ccRCC and Oncocytoma usingcontrast-enhanced computed tomography (CECT) images. Whole lesions were manually segmented on the nephrographicphase using Synapse 3D (Fujifilm, CT) and co-registered to other phases of multiphase CT acquisitions for each tumor. Afirst-generation curvelet transform code was used to apply forward, inverse transform to segmented images, and texturemetrics were extracted from each CT phase. Histopathological diagnosis was obtained following surgical resection. AWilcoxon rank-sum test showed that curvelet-based metric: energy on corticomedullary phase was significantly (p <0.005)higher in oncocytoma (0.06±0.04) than ccRCC (0.04±0.05). Higher values of energy are associated with homogenoustextures. A supportive receiver operator characteristics analysis based on energy metric revealed reasonable discrimination(AUC >0.7, p <0.05) between ccRCC and oncocytoma. We conclude based on these preliminary results that curveletbasedenergy metric can differentiate between ccRCC and oncocytoma based on their CECT data. In combination withother metrics, curvelet metrics may advance radiomic analysis in evaluating clinical imaging data.
机译:临床成像技术在鉴别透明细胞肾细胞癌等恶性肿瘤中具有低精度。(CCRCC)和良性肿瘤,如儿肾细胞瘤。纹理指标I.E.,评估灰度级别的变化的指标从常规临床图像中提取的感兴趣区域的强度已经显示出有希望的成果这个目标。探索图像肿瘤行为与纹理指标之间的关系,我们测试基于2D Curlc的变换纹理分析在CCRCC和儿科瘤之间使用的有效性对比度增强的计算机断层扫描(CECT)图像。整个病变在丛中手动细分使用Synapse 3D(Fujifilm,CT)的相位,并且对每个肿瘤的多相CT采集的其他阶段共登记。一种第一代Curvelet转换代码用于应用前进,逆变换为分段图像和纹理从每个CT相提取度量。手术切除后获得组织病理学诊断。一种Wilcoxon Rank-Sum试验显示Curvelet的公制:皮质体髓质相对的能量显着(P <0.005)高肾细胞瘤(0.06±0.04)高于CCRCC(0.04±0.05)。能量较高的能量值与均匀相关纹理。基于能量度量的支持性接收器操作者特性分析显示合理的歧视(AUC> 0.7,P <0.05)在CCRCC和心细胞瘤之间。我们基于卷曲的初步结果,得出结论能量度量可以基于其CECT数据来区分CCRCC和心细胞瘤之间。结合其他度量,Curvelet度量可以提前评估临床成像数据的辐射瘤分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号